Winnergy Medical PCL (BKK:WINMED)
Thailand · Delayed Price · Currency is THB 1.150
-0.020 (-1.71%)
Sep 3, 2026, 4:22 PM ICT
Winnergy Medical PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 699.71 | 647.04 | 654.36 | 639.18 | 703.41 | 538.64 | |
Revenue Growth | 2.59% | -1.12% | 2.37% | -9.13% | 30.59% | 1.53% |
Cost of Revenue | 400.39 | 370.72 | 387.69 | 380.75 | 441.55 | 295.37 |
Gross Profit | 299.32 | 276.32 | 266.66 | 258.43 | 261.87 | 243.27 |
Selling, General & Admin | 288.96 | 267.92 | 242.19 | 221.37 | 203.68 | 186.24 |
Operating Expenses | 288.96 | 267.92 | 242.19 | 221.37 | 203.68 | 186.24 |
Operating Income | 10.36 | 8.4 | 24.47 | 37.06 | 58.18 | 57.03 |
Interest Expense | -15.73 | -15.91 | -12.17 | -9.07 | -6.87 | -4.94 |
Interest & Investment Income | 2.55 | 2.76 | 2.66 | 4.68 | 16.1 | 17.56 |
Currency Exchange Gain (Loss) | 1.05 | 0.87 | 1.14 | 0.83 | - | - |
Other Non Operating Income (Expenses) | 4.72 | 12.43 | 1.12 | 1.76 | 1.66 | 0.78 |
EBT Excluding Unusual Items | 2.94 | 8.54 | 17.22 | 35.25 | 69.07 | 70.44 |
Gain (Loss) on Sale of Assets | 19.24 | 10.53 | 12.19 | - | - | - |
Other Unusual Items | - | - | 4.57 | - | 0.45 | 1.73 |
Pretax Income | 22.18 | 19.07 | 33.97 | 35.25 | 69.52 | 72.16 |
Income Tax Expense | 5.39 | 3.9 | 4.71 | 4.61 | 8.85 | 6.96 |
Net Income | 16.79 | 15.17 | 29.26 | 30.64 | 60.67 | 65.21 |
Net Income to Common | 16.79 | 15.17 | 29.26 | 30.64 | 60.67 | 65.21 |
Net Income Growth | -46.97% | -48.15% | -4.50% | -49.50% | -6.96% | 26.39% |
Shares Outstanding (Basic) | 400 | 400 | 400 | 400 | 400 | 359 |
Shares Outstanding (Diluted) | 400 | 400 | 400 | 400 | 400 | 359 |
Shares Change | - | - | - | - | 11.55% | 119.55% |
EPS (Basic) | 0.04 | 0.04 | 0.07 | 0.08 | 0.15 | 0.18 |
EPS (Diluted) | 0.04 | 0.04 | 0.07 | 0.08 | 0.15 | 0.18 |
EPS Growth | -46.97% | -48.15% | -4.50% | -49.50% | -16.59% | -42.43% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 45.72 | -43.79 | -67.37 | -46.1 | -131.78 | -48.66 |
Free Cash Flow Per Share | 0.11 | -0.11 | -0.17 | -0.12 | -0.33 | -0.14 |
Dividend Per Share | 0.013 | 0.013 | 0.025 | 0.029 | 0.057 | 0.065 |
Dividend Growth | -49.49% | -49.49% | -16.10% | -48.16% | -12.46% | -56.35% |
Gross Margin | 42.78% | 42.70% | 40.75% | 40.43% | 37.23% | 45.16% |
Operating Margin | 1.48% | 1.30% | 3.74% | 5.80% | 8.27% | 10.59% |
Profit Margin | 2.40% | 2.34% | 4.47% | 4.79% | 8.63% | 12.11% |
Free Cash Flow Margin | 6.53% | -6.77% | -10.29% | -7.21% | -18.73% | -9.03% |
EBITDA | 50.99 | 52.38 | 67.93 | 75.7 | 93.15 | 82.45 |
EBITDA Margin | 7.29% | 8.09% | 10.38% | 11.84% | 13.24% | 15.31% |
D&A For EBITDA | 40.63 | 43.98 | 43.46 | 38.64 | 34.96 | 25.41 |
EBIT | 10.36 | 8.4 | 24.47 | 37.06 | 58.18 | 57.03 |
EBIT Margin | 1.48% | 1.30% | 3.74% | 5.80% | 8.27% | 10.59% |
Effective Tax Rate | 24.30% | 20.45% | 13.88% | 13.09% | 12.73% | 9.64% |
Revenue as Reported | 699.71 | 647.04 | 654.36 | 639.18 | 703.41 | 538.64 |
Advertising Expenses | - | 16.46 | 17.18 | 17.26 | 18.95 | 12.5 |